{"id":31175,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/","title":{"rendered":"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1479 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruselas 2018<\/h2>\n<p>Este breve episodio est\u00e1 dedicado a un comentario adicional de uno de los pacientes sobre las soluciones propuestas.<\/p>\n<h3>Panelistas<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1480 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Reproductor de v\u00eddeo de YouTube\" src=\"https:\/\/www.youtube.com\/embed\/O-te1OPONl4?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruselas 2018 Este breve episodio est\u00e1 dedicado a un comentario adicional de uno de los pacientes sobre las soluciones propuestas. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.<\/p>\n","protected":false},"author":1,"featured_media":31193,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[202],"tags":[176,179,203,205,206],"class_list":["post-31175","news","type-news","status-publish","has-post-thumbnail","hentry","category-debates-futuros-de-rinologia","tag-profesionales-sanitarios","tag-biologicos","tag-rinologia","tag-debates","tag-debates-futuros-de-rinologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruselas 2018 Este breve episodio est\u00e1 dedicado a un comentario adicional de uno de los pacientes sobre las soluciones propuestas. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/\",\"name\":\"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/elige-tu-camino\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/","og_locale":"es_ES","og_type":"article","og_title":"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico","og_description":"Rhinology Future Debates Bruselas 2018 Este breve episodio est\u00e1 dedicado a un comentario adicional de uno de los pacientes sobre las soluciones propuestas. Panelistas Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, representantes de pacientes.","og_url":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/","url":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/","name":"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/es\/news\/perspectivas-del-paciente-sobre-la-adopcion-del-tratamiento-biologico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.euforea.org\/es\/elige-tu-camino\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/es\/news\/"},{"@type":"ListItem","position":3,"name":"Perspectivas del paciente sobre la adopci\u00f3n del tratamiento biol\u00f3gico"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/es\/#website","url":"https:\/\/www.euforea.org\/es\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/es\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/comments?post=31175"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/31175\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media\/31193"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media?parent=31175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/categories?post=31175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/tags?post=31175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}